Abstract
Carcinoembryonic antigen (CEA) is a complex glycoprotein produced by 90% of colorectal cancers (CRC). Preoperative CEA level is considered as a predictive factor of survival in CRC patients. However, the prognostic significance of elevated preoperative CEA that normalized after resection is unknown. We aim through this study to assess the role of variations of preoperative and postoperative CEA levels in predicting nonmetastatic CRC relapse.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
